Registration:
This program is $5 to attend for ICHP members. Non-members will not be allowed to attend. Register below. You must register online in advance to attend this program. Please bring a copy of your registration verification form with you to the meeting. Registration deadline is November 14, 2017.
Learning Objectives for Pharmacists:
- Identify anticancer agents associated with cardiomyopathy.
- Explain the difference between subclinical and clinical chemotherapy-induced cardiomyopathy and the importance of its early detection.
- Identify new imaging and biomarker monitoring parameters available for early detection of chemotherapy-induced cardiomyopathy.
- Describe the role of traditional heart failure therapies in the prevention and treatment of chemotherapy-induced cardiomyopathy.
Learning Objectives for Technicians:- Identify anticancer agents that are associated with causing heart failure.
- Explain the importance of early detection heart muscle damage from chemotherapy agents.
- List traditional heart failure medications that have shown to be beneficial in the prevention of chemotherapy-induced heart failure.
Accreditation:
Universal Activity Numbers (UANs): 0121-0000-17-120-L01-P & 0121-0000-17-120-L01-T
1.0 Contact Hour (0.1 CEU) Type of Activity: Knowledge-based
The Illinois Council of Health System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
To receive your CPE credit, you will need to complete the online evaluation forms and then your credit will automatically be reported to CPE Monitor. Information on accessing the online evaluation system will be provided at the meeting.
PTCB now requires CPhTs to earn only pharmacy technician-specific (‘T-specific’) credit to qualify for recertification. As of January 1, 2015, ALL CPE credit earned must be T-specific. In addition, PTCB reduced the number of allowable CPE hours earned through in-service training from 10 to 5. Please advise all pharmacy technicians at your site of this change.
Target Audience: Health-System Pharmacists and Pharmacy Technicians
Faculty Disclosure:
It is the policy of ICHP to ensure balance, independence, objectivity, and scientific rigor in all of its education programs. In accordance with this policy, faculty must disclose to the participants any significant relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of these continuing pharmacy education programs. These disclosures will be available at the program.
